155 related articles for article (PubMed ID: 21792088)
1. Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle.
Fogar P; Basso D; Fadi E; Greco E; Pantano G; Padoan A; Bozzato D; Facco M; Sanzari MC; Teolato S; Zambon CF; Navaglia F; Semenzato G; Pedrazzoli S; Plebani M
Pancreas; 2011 Oct; 40(7):1131-7. PubMed ID: 21792088
[TBL] [Abstract][Full Text] [Related]
2. Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma.
Nummer D; Suri-Payer E; Schmitz-Winnenthal H; Bonertz A; Galindo L; Antolovich D; Koch M; Büchler M; Weitz J; Schirrmacher V; Beckhove P
J Natl Cancer Inst; 2007 Aug; 99(15):1188-99. PubMed ID: 17652277
[TBL] [Abstract][Full Text] [Related]
3. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
[TBL] [Abstract][Full Text] [Related]
4. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
5. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E
Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488
[TBL] [Abstract][Full Text] [Related]
7. CD38 identifies a hypo-proliferative IL-13-secreting CD4+ T-cell subset that does not fit into existing naive and memory phenotype paradigms.
Scalzo-Inguanti K; Plebanski M
Eur J Immunol; 2011 May; 41(5):1298-308. PubMed ID: 21469087
[TBL] [Abstract][Full Text] [Related]
8. CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions.
Sugita K; Hirose T; Rothstein DM; Donahue C; Schlossman SF; Morimoto C
J Immunol; 1992 Nov; 149(10):3208-16. PubMed ID: 1358967
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T-cell subsets defined by expression of CD45 isoforms differ in their capacity to produce IL-2, IFN-gamma and TNF-beta.
Adamthwaite D; Cooley MA
Immunology; 1994 Feb; 81(2):253-60. PubMed ID: 7908892
[TBL] [Abstract][Full Text] [Related]
11. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
12. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients.
Li L; Lao SH; Wu CY
Tuberculosis (Edinb); 2007 Nov; 87(6):526-34. PubMed ID: 17851131
[TBL] [Abstract][Full Text] [Related]
13. Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
Ebelt K; Babaryka G; Figel AM; Pohla H; Buchner A; Stief CG; Eisenmenger W; Kirchner T; Schendel DJ; Noessner E
Prostate; 2008 Jan; 68(1):1-10. PubMed ID: 17948280
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of sodium arsenite during the activation of human CD4+ and CD8+ T lymphocytes.
Tenorio EP; Saavedra R
Int Immunopharmacol; 2005 Dec; 5(13-14):1853-69. PubMed ID: 16275621
[TBL] [Abstract][Full Text] [Related]
15. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
Gessl A; Waldhäusl W
J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
[TBL] [Abstract][Full Text] [Related]
16. Circulating CD4+CD25 high regulatory T cells and natural killer T cells in children with newly diagnosed type 1 diabetes or with diabetes-associated autoantibodies.
Oling V; Marttila J; Knip M; Simell O; Ilonen J
Ann N Y Acad Sci; 2007 Jun; 1107():363-72. PubMed ID: 17804564
[TBL] [Abstract][Full Text] [Related]
17. Human retinal pigment epithelium-induced CD4+CD25+ regulatory T cells suppress activation of intraocular effector T cells.
Horie S; Sugita S; Futagami Y; Yamada Y; Mochizuki M
Clin Immunol; 2010 Jul; 136(1):83-95. PubMed ID: 20350837
[TBL] [Abstract][Full Text] [Related]
18. Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans.
Hengel RL; Jones BM; Kennedy MS; Hubbard MR; McDougal JS
J Immunol; 1999 Sep; 163(6):3539-48. PubMed ID: 10477629
[TBL] [Abstract][Full Text] [Related]
19. Human CD4+CD45R0+ and CD4+CD45RA+ T cells synergize in response to alloantigens.
Akbar AN; Salmon M; Ivory K; Taki S; Pilling D; Janossy G
Eur J Immunol; 1991 Oct; 21(10):2517-22. PubMed ID: 1680701
[TBL] [Abstract][Full Text] [Related]
20. Human primary adenotonsillar naïve phenotype CD45RA CD4 T lymphocytes undergo apoptosis upon stimulation with a high concentration of CD3 antibody.
Pajusto M; Tarkkanen J; Mattila PS
Scand J Immunol; 2005 Dec; 62(6):546-51. PubMed ID: 16316422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]